Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.6590
-0.0109 (-1.63%)
May 20, 2025, 4:00 PM - Market closed
Biofrontera Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 38 | 37.32 | 34.07 | 28.67 | 24.1 | 18.85 | Upgrade
|
| Revenue Growth (YoY) | 14.28% | 9.54% | 18.82% | 18.98% | 27.86% | -28.01% | Upgrade
|
| Cost of Revenue | 17.76 | 18.61 | 17.44 | 15.19 | 12.74 | 9.07 | Upgrade
|
| Gross Profit | 20.24 | 18.71 | 16.63 | 13.49 | 11.36 | 9.78 | Upgrade
|
| Selling, General & Admin | 33.25 | 33.84 | 37.9 | 35 | 25.96 | 18.12 | Upgrade
|
| Research & Development | 3.28 | 2.09 | 0.08 | - | - | - | Upgrade
|
| Operating Expenses | 36.53 | 35.92 | 37.98 | 35 | 25.96 | 18.12 | Upgrade
|
| Operating Income | -16.29 | -17.21 | -21.35 | -21.51 | -14.6 | -8.33 | Upgrade
|
| Interest Expense | -0.81 | -2.11 | -0.6 | -0.37 | -0.36 | -2.9 | Upgrade
|
| Interest & Investment Income | 0.07 | 0.07 | 0.13 | 0.18 | 0.02 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.03 | 0.03 | -0.11 | -0.03 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 5.34 | 1.64 | 3.04 | 16.36 | -12.65 | 0.08 | Upgrade
|
| EBT Excluding Unusual Items | -11.66 | -17.58 | -18.89 | -5.38 | -27.6 | -11.12 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.75 | -1.13 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.02 | -0.01 | -7.42 | 1.75 | - | - | Upgrade
|
| Legal Settlements | - | - | 6.16 | -0.87 | -11.25 | - | Upgrade
|
| Other Unusual Items | 0.17 | -0.15 | 0.03 | 3.89 | 1.94 | 1.33 | Upgrade
|
| Pretax Income | -11.51 | -17.74 | -20.12 | -0.61 | -37.66 | -10.92 | Upgrade
|
| Income Tax Expense | 0.02 | 0.02 | 0.01 | 0.03 | 0.06 | 0.06 | Upgrade
|
| Net Income | -11.53 | -17.76 | -20.13 | -0.64 | -37.71 | -10.99 | Upgrade
|
| Net Income to Common | -11.53 | -17.76 | -20.13 | -0.64 | -37.71 | -10.99 | Upgrade
|
| Shares Outstanding (Basic) | 7 | 6 | 2 | 1 | 0 | - | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 6 | 2 | 1 | 0 | - | Upgrade
|
| Shares Change (YoY) | 222.35% | 256.75% | 46.29% | 140.00% | - | - | Upgrade
|
| EPS (Basic) | -1.69 | -3.22 | -13.02 | -0.61 | -85.63 | - | Upgrade
|
| EPS (Diluted) | -1.69 | -3.22 | -13.02 | -0.61 | -85.63 | - | Upgrade
|
| Free Cash Flow | - | -10.28 | -24.9 | -16.24 | -26.73 | -12.37 | Upgrade
|
| Free Cash Flow Per Share | - | -1.86 | -16.10 | -15.36 | -60.68 | - | Upgrade
|
| Gross Margin | 53.26% | 50.14% | 48.80% | 47.04% | 47.13% | 51.90% | Upgrade
|
| Operating Margin | -42.87% | -46.11% | -62.67% | -75.02% | -60.59% | -44.21% | Upgrade
|
| Profit Margin | -30.33% | -47.58% | -59.09% | -2.23% | -156.49% | -58.29% | Upgrade
|
| Free Cash Flow Margin | - | -27.54% | -73.08% | -56.63% | -110.90% | -65.62% | Upgrade
|
| EBITDA | -15.89 | -16.79 | -20.85 | -20.99 | -14.06 | -7.77 | Upgrade
|
| EBITDA Margin | -41.82% | -44.98% | -61.19% | -73.21% | -58.34% | -41.23% | Upgrade
|
| D&A For EBITDA | 0.4 | 0.42 | 0.5 | 0.52 | 0.54 | 0.56 | Upgrade
|
| EBIT | -16.29 | -17.21 | -21.35 | -21.51 | -14.6 | -8.33 | Upgrade
|
| EBIT Margin | -42.87% | -46.11% | -62.67% | -75.02% | -60.59% | -44.21% | Upgrade
|
| Revenue as Reported | 38 | 37.32 | 34.07 | 28.67 | 24.1 | 18.85 | Upgrade
|
| Advertising Expenses | - | - | 0.2 | 0.1 | 0.5 | - | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.